Legal & Disputes ·
Halper Sadeh Investigates Whether Aytu BioPharma's $2.70-Per-Share Rosemont Sale Is Fair
Halper Sadeh LLC is investigating Aytu BioPharma's $2.70-per-share sale to Rosemont Pharmaceuticals over whether shareholders are getting a fair price.